BASP1 and acute myeloid leukemia: Decitabine has also been shown to upregulate BASP1, which is epigenetically silenced (via methylation of the BASP1-promoter region) in acute myeloid leukemias characterized by the t(8;21) translocation (Zhou et al., 2018).